TTNP
Closed
Titan Pharmaceuticals Inc
5.73
-0.18 (-3.05%)
Last Update: 06 Sep 2024 23:00:00
Yesterday: 5.91
Day's Range: 5.61 - 6.14
Send
sign up or login to leave a comment!
When Written:
0.7902
Titan Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development of innovative treatments for serious medical conditions. The company's primary focus is on the development of products for the treatment of opioid addiction and other substance abuse disorders.
Titan Pharmaceuticals Inc's flagship product is Probuphine, a subdermal implant that delivers a continuous dose of buprenorphine, a medication used to treat opioid addiction. The company also has a pipeline of other products in development, including products for the treatment of Parkinson's disease and hypothyroidism.
Titan Pharmaceuticals Inc was founded in 1992 and is headquartered in South San Francisco, California. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol TTNP.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Titan Pharmaceuticals Inc's flagship product is Probuphine, a subdermal implant that delivers a continuous dose of buprenorphine, a medication used to treat opioid addiction. The company also has a pipeline of other products in development, including products for the treatment of Parkinson's disease and hypothyroidism.
Titan Pharmaceuticals Inc was founded in 1992 and is headquartered in South San Francisco, California. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol TTNP.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!